文献速递脑血管病

抑制CD147通过减少血栓炎症改善小鼠急性缺血性卒中

Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation.
PubMed 文献 · Stroke · 2017-11-07

该研究在C57BL/6小鼠中采用60分钟短暂大脑中动脉闭塞模型,给予抗CD147功能阻断抗体或同型对照抗体。结果显示抑制CD147可减小梗死体积、改善神经功能,机制与减轻血脑屏障损伤、减少血栓形成及炎症细胞浸润相关。

要点

  • 抑制CD147可减小小鼠短暂大脑中动脉闭塞后梗死体积并改善神经功能。
  • CD147抑制的神经保护作用与减少血脑屏障损伤、血栓形成和炎症细胞浸润相关。
  • CD147可能成为缺血性卒中及血栓炎症性疾病的新治疗靶点。

核心结论

  • 抑制CD147通过减少血栓炎症改善小鼠急性缺血性卒中。
  • CD147可能是缺血性卒中及可能其他血栓炎症性疾病的新治疗靶点。

研究设计与样本

  • C57BL/6小鼠行60分钟短暂大脑中动脉闭塞诱导局灶性脑缺血。
  • 动物接受抗CD147功能阻断抗体或同型对照抗体治疗。

主要发现

  • 短暂大脑中动脉闭塞后缺血脑内皮CD147表达快速增加。
  • 抑制CD147减小梗死体积并改善第3天功能结局。
  • 神经保护作用与防止血脑屏障损伤、减少血管内纤维蛋白和血小板沉积从而减少血栓形成并增加脑灌注、减少脑炎症细胞浸润相关。
  • 机制可能包括减少脑微血管内皮细胞中NF-κB活化、MMP-9活性和PAI-1表达。

临床怎么用

  • CD147抑制可能作为急性缺血性卒中的潜在治疗策略,但尚需临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Inflammation and thrombosis currently are recognized as critical contributors to the pathogenesis of ischemic stroke. CD147 (cluster of differentiation 147), also known as extracellular matrix metalloproteinase inducer, can function as a key mediator of inflammatory and immune responses. CD147 expression is increased in the brain after cerebral ischemia, but its role in the pathogenesis of ischemic stroke remains unknown. In this study, we show that CD147 acts as a key player in ischemic stroke by driving thrombotic and inflammatory responses. METHODS: Focal cerebral ischemia was induced in C57BL/6 mice by a 60-minute transient middle cerebral artery occlusion. Animals were treated with anti-CD147 function-blocking antibody (αCD147) or isotype control antibody. Blood-brain barrier permeability, thrombus formation, and microvascular patency were assessed 24 hours after ischemia. Infarct size, neurological deficits, and inflammatory cells invaded in the brain were assessed 72 hours after ischemia. RESULTS: CD147 expression was rapidly increased in ischemic brain endothelium after transient middle cerebral artery occlusion. Inhibition of CD147 reduced infarct size and improved functional outcome on day 3 after transient middle cerebral artery occlusion. The neuroprotective effects were associated with (1) prevented blood-brain barrier damage, (2) decreased intravascular fibrin and platelet deposition, which in turn reduced thrombosis and increased cerebral perfusion, and (3) reduced brain inflammatory cell infiltration. The underlying mechanism may include reduced NF-κB (nuclear factor κB) activation, MMP-9 (matrix metalloproteinase-9) activity, and PAI-1 (plasminogen activator inhibitor-1) expression in brain microvascular endothelial cells. CONCLUSIONS: Inhibition of CD147 ameliorates acute ischemic stroke by reducing thromboinflammation. CD147 might represent a novel and promising therapeutic target for ischemic stroke and possibly other thromboinflammatory disorders.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Jin R, Xiao AY, Chen R, et al. Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation. Stroke. 2017. PMID: 29114092. doi:10.1161/STROKEAHA.117.018839

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。